NCT03552471
- Conditions
- Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +24 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Folate Receptor Alpha Positive
Explore clinical trials studying Folate Receptor Alpha Positive. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Folate Receptor Alpha Positive trial results
Completed
Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
NCT03106077
- Conditions
- Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States